EVENTS|NEWS|CONTACT|DONATE
Read Our Newsletter

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
cancer drugs trials
May 25 2018

Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer

Here’s some positive news to kick off the weekend! A clinical trial of Lonsurf (trifluridine and tipiracil) plus supportive care improved overall survival for previously treated metastatic gastric cancer patients, compared to a placebo plus supportive care. The drug will now head to the FDA for consideration.

Read Source
,

Social Media

   

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Please join with us to fuel the next wave of progress.

Your support honors the memories of those we have lost and creates much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2025 Fundraising Campaign.

Your support honors the memories of those we have lost and creates much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Powering progress to defeat stomach cancer.

Powering progress to defeat stomach cancer.

MORE INFODONATEDONATEMORE INFO
X